PRCT vs REG · rev $224.5M vs P/E 34, $12.93B cap
Procept Biorobotics Corp (PRCT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
REG does not have a complete income-statement cache yet.
PRCT currently screens at market cap $1.52B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the PRCT and REG stock pages for the full models.
Not investment advice.